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Abstract:     
Prions are units of propagation of an altered state of a protein or proteins. 
Prions can propagate from cell to cell, and from organism to organism, through 
cooption of other protein copies. Prions contain no necessary nucleic acids, and 
are important both as both pathogenic agents, and as a potential force in 
epigenetic phenomena. The original prions were derived from a misfolded form of 
the mammalian Prion Protein PrP. Infection by these prions causes 
neurodegenerative diseases. Other prions cause non-Mendelian inheritance in 
budding yeast, and sometimes act as diseases of yeast. We have compiled a 
database of >2000 prion-related sequences, called the PrionOme. The database 
comprises seven PrionOme classification categories: prionogenic sequences 
(i.e., sequences that can make prions), "prionoids! (i.e., phenomena that have 
some prion characteristics), orthologs, paralogs, pseudogenes, prion interactors, 
and prion-like molecules. Database entries list: supporting information for 
PrionOme classifications, prion-determinant areas (where relevant), and 
disordered and compositionally-biased regions. Also included are original 
references for the PrionOme classifications, transcripts and genomic coordinates, 
and structural data (including comparative models). We provide database usage 
examples for both vertebrate and fungal prion contexts. As development of this 
resource is on-going, we will be very happy to receive and act on any 
constructive comments from peer scientists in the areas of prion biology and 
protein misfolding, either by email or using the feedback form provided on the 
PrionOme website. We hope that this database will be a valuable experimental 
aid and reference resource. It is freely available at: 
http://libaio.biol.mcgill.ca/prion.   
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Background  
 
Prions are alternative, propagating states of normal cellular proteins. 
Prions were originally defined as the causative agent of mammalian transmissible 
spongiform encephalopathies (TSEs), diseases which include scrapie in sheep 
and Creutzfeldt-Jakob disease (CJD) in humans (1). CJD involves progressive 
dementia, and death within a year of diagnosis. TSEs can arise in inherited, 
sporadic or infectious forms. Infectious prions lack nucleic acids (1), and rely on 
the presence of a host prion-protein gene for propagation (2). Whereas the 
normal cellular form of the prion protein (PrP-C) is mostly alpha-helical (3,4), the 
infectious form of the prion protein (PrP-Sc), is mostly beta-sheet (5), which 
indicates a dramatic conformational change in the infectious protein.  
The prion protein (PrP) is highly conserved across mammals, typically with 
>50% sequence identity relative to human PrP (6,7). PrP maintains very high 
sequence conservation (>95%) in regions associated with disease, and also 
conserves a metal ion–binding repetitive region whose copy number is implicated 
in some human prion diseases (9). Mammalian PrP paralogs have continued to 
be discovered and have been demonstrated to be of neurological relevance and 
functionally linked to PrP (10). Doppel is a divergent PrP homolog (~25% 
sequence identity), that is mainly expressed in the testis, and can cause 
neurodegeneration when aberrantly expressed in the central nervous system 
(CNS) (10). A second paralog of PrP, dubbed Shadoo, is more highly conserved 
across vertebrates, than either Doppel or PrP. Shadoo intriguingly shares a high 
degree of sequence identity with PrP in the short alanine-rich stretch that forms a 
transmembrane alpha-helix in some disease-associated PrP products (11). 
Shadoo is expressed in the CNS, and both Shadoo and PrP-C can counteract 
Doppel neurotoxicity in a similar way (12). PrP homologs have also been 
observed in fish (13), and extensive genome-scale analyses in vertebrates have 
led to the discovery of additional gene and pseudogene family members for PrP 
(14). Moreover, distant homology to ectodomains in the ZIP family of proteins 
linked to cytosolic divalent metal ion import, indicates that the PrP gene family 
may have originated from an ancestral ZIP sequence in an early common 
metazoan ancestor (15).  
Apart from the original infectious prion phenomena just described, prions 
have been defined in other organisms. In the budding yeast S. cerevisiae, prions 
have been identified as cytoplasmic or nuclear elements inherited in a non-
Mendelian fashion (16-18). The first two yeast prions discovered were [PSI+] and 
[URE3] (16,17,19). [PSI+] arises from propagation of a misfolded amyloid form of 
Sup35p, part of the translation termination complex. Formation of [PSI+] prions 
reduces the efficiency of translation termination and increases levels of 
nonsense-codon readthrough (17,20,21). Such readthrough has been 
demonstrated to be a potential mechanism to uncover cryptic genetic variation 
(22,23). [URE3], the prion form of the nitrogen catabolism protein Ure2p, 
functions to up-regulate poor nitrogen source usage, even when rich sources are 
 4 
available (16,18,24). Prions may also be considered as diseases of budding 
yeast, in certain contexts (25,26). A defining characteristic of the known yeast 
prions is a region with an obvious bias for glutamine (Q) and/or asparagine (N) 
residues (27-30). Mutation of these residues diminishes or abolishes prion 
formation (29,30). Previously, we have shown that Q/N biases are maintained in 
fungi that are estimated to have diverged from each other ~1 billion years ago; 
furthermore, there is evidence for purifying selection, to varying degrees, on 
different prion domains or subdomains (31). Several hundred prion-like domains 
(with pronounced Q/N bias) occur in the proteomes of diverse fungi and higher 
eukaryotes (27,31,32).   
The universe of prion phenomena continues to expand (33-37). For 
example, in budding yeast, a prion that is formed by the CYC8 protein is part of a 
transcriptional regulatory complex that regulates 7% of yeast genes, thus 
potentially regulating their expression en masse (38). Although the vast majority 
of described prions arise via propagation of alternative amyloid states of proteins, 
other types of prions are possible, such as the [!] prion, which arises through 
propagation of the auto-activated state of yeast protease B (39). Also, some 
amyloids, dubbed 'prionoids', may exhibit evidence of prion-like propagation in 
some contexts or experimental conditions (40).   
Here, we report the availability of a public-domain resource, the PrionOme 
database. This database enables tracking of the rapidly growing corpus of prion 
phenomena and prion-related sequence data. The PrionOme comprises curated 
information about prions, prionogenic sequences, "prionoids!, prion protein 
orthologs and paralogs, pseudogenes (i.e., genes copies that appear to have lost 
their protein-coding ability), prion protein interactors and prion-like molecules. 
 
Database Construction & Content  
 
Database structure  
The PrionOme database is a record-based database, similar in format to 
the DisProt database (41). It is managed and updated using the SQL and PHP 
scripting languages. The individual database entries are for single sequences. A 
screen-shot example is depicted in Figure 1. This is the database entry for a 
duplicated transcribed pseudogene in the human genome that is homologous to 
Sprn, the gene encoding the Shadoo protein. Database entries are indexed by 
Prion Identifier (which is in the form PDxxxx, where xxxx is a four-digit number), 
and also by PrionOme Classification (which is explained below in the section 
describing the database entry format). The source data and its collation, is 
described below for each field of the entry format. Redundant identical sequence 
entries in the database (either for full-length or fragmentary sequences) were 
curated and removed.  
 
Database Entry Format 
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 There are nine sections for each database entry. The sections are as 
follows:  
 
(i) General Information:  
  This first section contains the following data:  
 
Prion ID: A unique identifier for each entry in the database. It is in the format 
PDxxxx, where xxxx is a four-digit number.  
 
UniProt accession and SwissProt ID: This is the UniProt/SwissProt identification 
corresponding to protein sequences that can be found in UniProt/SwissProt. 
Some PrionOme entries (e.g., new genome annotations for Prion Protein 
homologs, or pseudogenes) do not have a UniProt/SwissProt identification.  
 
Source Organism and Taxonomy: This is the full binomial name of the source 
organism. The equivalent English name is usually given in brackets.  
 
Sequence length: This is in residues.  
 
Protein Name: This is a full descriptive name of the protein.  
 
Prion Name: This applies only to 'prionogenic' sequences, i.e., sequences that 
can make prions. The name of the prion phenomenon for which the sequence is 
prionogenic is indicated. Prion Names follow the standard convention for prions 
in fungal genetics (42). The original pathogenic prion in mammals has been given 
the name [PrP TSE prion]. Entries labeled 'Alberti, et al (2009) data', are proteins 
from the analysis of Alberti, et al. (33), which were indicated as likely prions via a 
combination of fluorescence microscopy, SDD-AGE analysis, Sup35C prion 
assay and in vitro assembly assay (33).   
 In addition, the Prion Type is given. Prions are classified into four types 
based on the classification in the review article by Wickner, et al. (43). These 
Types are as follows:  
  Type 1: The prion state of the protein is a pathogenic or toxic amyloid/amyloid-
like form.  
  Type 2: The prion state of the protein is an inactive amyloid/amyloid-like form, 
but may cause partial loss of normal function of the protein. This may lead to 
epigenetic phenomena, such as uncovering hidden genetic variation, in the case 
of the [PSI+] prion.  
  Type 3: The prion state of the protein is an amyloid/amyloid-like form that is the 
major active functional form of the protein.  
  Type 4: The prion state is an active state of an enzyme.  
 
Sequence: This is the amino-acid sequence in one-letter code.  
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(ii) PrionOme Classification:  
This section of the database entry contains the PrionOme classification, 
as well as a short description of the supporting information for this classification. 
The total numbers of entries with each PrionOme Classification is summarized in 
Table 1. The PrionOme Classification can be one or more of the following:  
 
Prionogenic: A protein sequence that is known to form prions. These were 
collated by the database authors from the literature.  
 
Ortholog: An ortholog of a sequence that is known to form prions. Orthologs are 
the mutually most similar sequences in different organisms. These were 
calculated as orthologs using the bi-directional best hits approach. Some 
orthologous proteins are from novel genome annotations, annotated in Harrison, 
et al. (2010) (14).  
 
Paralog: A paralog of a sequence that is known to form prions. Paralogs are 
duplications of protein sequences within the same genome. Some orthologous 
proteins are from novel genome annotations, annotated in Harrison, et al. (2010) 
(14). ZIP metal-ion import proteins that contain a prion-like domain, that were 
detected through sensitive Hidden Markov Model analysis (15), are classified as 
paralogs in the PrionOme database.  
 
Prionoid: A sequence with incomplete evidence for prionogenicity, or which 
behaves in a prion-like way only in certain experimental contexts. The definition 
of 'prionoids' is discussed in the review Aguzzi and Rajendran (40).  
 
Prion-like: A protein sequence that contains a prion-like domain. Sequences are 
defined as prion-like if they have an obvious bias for glutamine and/or asparagine 
residues. Prion-like proteins in budding yeast were determined using the 
algorithms described in the ref. (44), with a maximum binomial P-value of 1x10–
10. Prion-like sequences defined for nematodes and other eukaryotes were taken 
from other sources (such as WormBase (45), for nematode sequences).  
 
Pseudogene: A copy of a prion-related gene that is formed via retrotransposition, 
or other processes of duplication, followed by coding-sequence disablement (46). 
These annotations were taken from Harrison, et al. (2010) (14), and other 
literature.  
 
Interactor: Proteins shown to interact with a prionogenic protein. Data in this first 
release of the PrionOme database are restricted to entries listed as binary 
interactors of prionogenic proteins, taken from the IntAct database (47).  
 
(iii) Prion Determinant:  
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This is the part of the protein sequence that forms the prion determinant, 
i.e., that is required for prionogenic activity. In this section, the method of 
determination for the prion determinant (curated from the literature), and its start 
and end points in the sequence, are indicated.  
 
(iv) Compositionally-Biased (CB) Regions:  
These are regions of the protein sequence that have a bias towards a 
subset of amino-acid residue types. They are defined using the algorithm 
described in refs. (27,44,48). In this section are indicated the following: the start 
and end points in the sequence; the binomial P-value for the CB region; the 
'signature' of the compositionally-biased region. In the signature are listed the 
one-letter codes of amino-acid residue types that define the biased region, in 
decreasing order of importance (44). That is, 'NY' indicates a region that is rich in 
N (asparagines) and Y (tyrosines). All compositional biases with binomial P-value 
<=10–7 are listed.  
 
(v) Known Disordered Regions:  
These are taken from the DisProt database (41). The ID from the DisProt 
database, and the start and end positions of the disordered region in the protein 
sequence are listed.  
 
(vi) Predicted Disordered Regions:  
 These are predicted using the DISOPRED algorithm, and default 
parameter values (49). The start and end positions of the predicted disordered 
region in the protein sequence are listed.  
 
(vii) References and Comments:  
References were curated from the literature. Original references are given 
that describe the demonstration of a prionogenic determinant, or, if not 
appropriate, for the sequencing of a prionogenic sequence, or ortholog or 
paralog. Additional references are provided if the sequence has been updated, or 
if additional significant sequence annotations are derived. Original references for 
the determination of interactors are also given. Comments on the other sections 
of the database entry are recorded in this section. Specifically also, for any 
sequence database entry, are listed the PrionOme Database identifiers (PDxxxx) 
of other sequences in the database, for which that sequence is an interactor, 
paralog or ortholog. For example, if PD8888 is an interactor of the prionogenic 
sequence PD7777, then the phrase, "Interacts with: PD7777! is listed in the 
Comment section of the entry for PD8888.    
 
 (viii) Genomic Information:  
In this section, we list the transcripts IDs (taken from the EMBL database); 
and the coordinates of the gene of the protein sequence in a recent genome 
assembly. These genome coordinate annotations are taken from the work in 
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Harrison, et al. (2010) (14), or otherwise transferred from the Ensembl database 
(50). Listed are the name of the genome assembly, the chromosome, strand 
direction and start and end points of each exon.  
 
(ix) Structure Information:  
Coordinates of structures for the PrionOme database entries are listed 
here. These are either experimental structures, or comparative models. 
Experimental structures are taken from the PDB (51). They are colour-coded 
according to the source of the data (Red for NMR spectroscopy;  Green for X-ray 
crystal structure; Magenta for EM (Electron Microscopy); and Blue for a 
comparative model). Comparative models were made using the program 
MODELLER (52) for PrP-related proteins for which the sequence alignment 
cannot be made automatically. These proteins occur in fish species, and tend to 
have large, interspersed disordered loops.  
 
 
User Interface  
The user interface is designed so that investigators can select and 
download subsets of prion-related sequence and annotation data, that are of 
interest. A comprehensive 'Help' page is provided. The database can be 
accessed by:  
(i) Browsing: A 'Browse' link on the home page enables users to browse 
the complete listing of PrionOme database entries and select any entries that 
they want. The selected entries can then be downloaded in complete database 
entry format, FASTA format (i.e., just the protein sequence), or as a CLUSTALW 
multiple sequence alignment (53), using the labeled buttons on the bottom of the 
display page.  
 (ii) Searching: Users can 'Search' either by keyword, by SQL query, or by 
BLAST interface. For keyword search, the database or field in which to search 
must be selected from a pull-down menu. For searching the sequences in the 
database, users can specify a regular expression of the sort used by the ELM 
database of linear motifs (54). A screenshot of a keyword search result for the 
phrase Anolis (a lizard) in the "Organism' field is shown in Figure 2. Database 
entries can be downloaded in one of three formats (complete database entry 
format, FASTA format or CLUSTALW multiple sequence alignment), as detailed 
above for 'Browsing'. For searching the database using the BLAST query box, 
the user can either paste in a single sequence in FASTA format, or upload one 
from a file, and then specify the parameters of the BLAST search.  
In addition, on the home page, there are links to convenient lists of 
database entries, grouped by: (i) Prion Name, (ii) PrionOme Classification, (iii) 
Organism, and (iv) Supporting Information for PrionOme Classification. In some 
cases, the database entries belong to more than one PrionOme Classification. 
For example, there are eleven database entries that are classified as both 
'Paralog' and 'Interactor'. There are separate links for these database entries that 
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have multiple PrionOme Classifications. A 'PrionOme News' window is also 
provided, in which updates and changes to the PrionOme database will be 
documented.  
 
Examples of Database Usage  
 We anticipate that the database will be useful as a reference resource for 
prion biologists, since it enables access to curated, up-to-date listings of a variety 
of prion-related sequences. In addition, the database will be useful to 
investigators as a bioinformatic aid to experimental design. Database entries 
contain cross-references to other database entries (that are interactors or 
homologs), and to relevant entries in other databases (e.g., DisProt (41)).  
 Database entry browsing can be informative for experimental design. For 
example, examination of the interactors of Ure2p, the protein that forms the 
[URE3] prion, produces some interesting results. The entry accession for Ure2p, 
the protein that forms the [URE3] prion, is PD0040. By keyword-searching in the 
"Comment! field for "Interacts with: PD0040!, we find a list of 70 proteins that 
interact with Ure2p. Browsing through these, we find several that are also 
candidate prions according to the survey of Alberti, et al. (33), e.g., the PrionOme 
database entry PD0734. This is the G-protein-coupled receptor GPR1, which was 
shown, via the dihydrofolate reductase reconstruction technique, to interact with 
Ure2p (55). The database entry indicates that GPR1 contains a long (>60 amino 
acid residues) region that is compositionally-biased for asparagine (N), similar to 
the prion determinant in Ure2p. This protein is thus a candidate for prion "cross-
seeding!, a potential mechanism through which prions can act as inducers of 
each other (56).  
In Tables 2 and 3, we have presented some data analysis of prion-related 
sequences resulting from queries to the PrionOme database, made using the 
SQL query interface. Firstly, for Table 2, we queried the PrionOme database for 
mammalian sequences of the Prion Protein (PrP) family, that have the sequence 
motif 'YYR'. This motif is an epitope for an antibody that is specific for the 
disease-related prion form of the PrP protein, PrPSc (57). We find that all of the 
PrP sequences that have so far been shown to be prionogenic, retain this YYR 
sequence motif, as well as the substantial majority of other sequences 
orthologous to PrP (Table 2). However, none of the paralogous sequences 
contain this tripeptide (Table 2).  
Secondly, as presented in Table 3, we investigated the composition of 
prion-related domains in Saccharomyces cerevisiae (budding yeast). Known 
prionogenic sequences in S. cerevisiae tend to have a pronounced bias for 
asparagine (N) and/or glutamine (Q) residues (31,44). A microcrystal structure of 
a small peptide fragment of the Sup35p prion determinant domain indicated that 
prion domains can be stabilized by hydrogen bonds between Q and N sidechains 
(58). Also, sidechains that contain six-membered rings, such as phenylalanine 
(F) and tyrosine (Y) may be able to interact in an arrangement termed " stacking 
(59). We checked how many of the prionogenic and prion-like sequences from 
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budding yeast in the PrionOme database also have a compositional bias for F or 
Y residues (Table 3). A significant fraction of the domains classed as prionogenic 
contain an F/Y compositional bias (5/28, 18%). Also, a smaller fraction of prion-
like domains (as defined in Methods), contain an F/Y compositional bias in their 
prion-like regions (21/306, 7%). Thus, these domains could use " stacking for 
amyloid stabilization, in addition to Q/N sidechain hydrogen-bonding interactions.  
 
Relationship to other databases 
There are no other published, currently maintained databases for prions 
and for the wide array of prion-related sequences that are encompassed in 
PrionOme. Two related published databases do however exist. The Prion 
Disease Database (PDDB) is a repository of time-course mRNA measurements 
for genes that may be related to prion disease (60). Also, AmyPDB, the amyloid 
precursor database, contains some information about a small subset of 
prionogenic sequences that have been demonstrated to propagate through 
amyloid formation (61). In the future, we will cross-reference our database with 
these two databases, where possible.  
 
Conclusions and future developments  
We have constructed PrionOme, a comprehensive database resource for 
prions and other prion-related molecules. We presented some examples of 
database utility for prion researchers. As PrionOme develops further, it will 
become increasingly useful for investigators as a reference database, and also 
as an aid for further experimental inquiry. Future developments will include the 
addition of mutation and polymorphism data for all entries in the database, some 
of which are not deposited in existing standard databases for protein sequence 
and genetic variation. We are currently performing quality control on the 
polymorphism data, and it will be added to the second version of the database in 
the near future. Also, the literature will be curated for new or overlooked reports 
of interactors of prionogenic proteins. A graphical display of features in the 
database sequences will also be added to each database entry. The database 
will be updated on a weekly basis to incorporate user-submitted data, to add 
new/overlooked data, and to cover new prions and prion-related phenomena, as 
they are discovered. More detailed comments, and more comprehensive lists of 
literature references, will also be added to the database entries, on a regular 
basis.  
As development of this resource is on-going, we will be very happy to 
receive and act on any constructive comments from peer scientists in the areas 
of prion biology and protein misfolding, either by email or via the "FeedBack! page 
on the PrionOme website.  
 
Acknowledgements  
 11 
 This work was funded to by a grant from the PrioNet Canada Network of 
Centres of Excellence to PH and RS. RS was also funded by the National Centre 
for Biological Sciences, and was a Senior Fellow of the Wellcome Trust (UK).  
 12 
 
References   
 
1. Prusiner, S.B. (1998) Prions. Proc Natl Acad Sci U S A, 95, 13363-13383. 
2. Prusiner, S.B., Groth, D., Serban, A., Koehler, R., Foster, D., Torchia, M., 
Burton, D., Yang, S.L. and DeArmond, S.J. (1993) Ablation of the prion 
protein (PrP) gene in mice prevents scrapie and facilitates production of anti-
PrP antibodies. Proc Natl Acad Sci U S A, 90, 10608-10612. 
3. Donne, D.G., Viles, J.H., Groth, D., Mehlhorn, I., James, T.L., Cohen, F.E., 
Prusiner, S.B., Wright, P.E. and Dyson, H.J. (1997) Structure of the 
recombinant full-length hamster prion protein PrP(29-231): the N terminus 
is highly flexible. Proc Natl Acad Sci U S A, 94, 13452-13457. 
4. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R. and 
Wuthrich, K. (1996) NMR structure of the mouse prion protein domain 
PrP(121-321). Nature, 382, 180-182. 
5. Pan, K., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., 
Mehlhorn, I., Huang, Z., Fletterick, R.J., Cohen, F.E. et al. (1993) Conversion 
of alpha-helices into beta-sheets features in the formation of the scrapie prion 
proteins. Proc Natl Acad Sci U S A. , 90, 10962-10966  
6. Schatzl, H.M., Da Costa, M., Taylor, L., Cohen, F.E. and Prusiner, S.B. 
(1995) Prion protein gene variation among primates. J Mol Biol, 245, 362-
374. 
7. Wopfner, F., Weidenhofer, G., Schneider, R., von Brunn, A., Gilch, S., 
Schwarz, T.F., Werner, T. and Schatzl, H.M. (1999) Analysis of 27 
mammalian and 9 avian PrPs reveals high conservation of flexible regions of 
the prion protein. J Mol Biol, 289, 1163-1178. 
 
9. Goldfarb, L.G., Brown, P., McCombie, W.R., Goldgaber, D., Swergold, G.D., 
Wills, P.R., Cervenakova, L., Baron, H., Gibbs, C.J., Jr. and Gajdusek, D.C. 
(1991) Transmissible familial Creutzfeldt-Jakob disease associated with five, 
seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc 
Natl Acad Sci U S A, 88, 10926-10930. 
10. Moore, R., Lee, I., Silverman, G., Harrison, P., Strome, R., Heinrich, C., 
Karunaratne, A., Pasternak, S., Chishti, M., Liang, Y. et al. (1997) Ataxia in 
prion protein (PrP)-deficient mice is associated with upregulation of the 
novel PrP-like protein doppel. J. Mol. Biol. , 292, 797-817. 
11. Hegde, R.S., Mastrianni, J.A., Scott, M.R., DeFea, K.A., Tremblay, P., 
Torchia, M., DeArmond, S.J., Prusiner, S.B. and Lingappa, V.R. (1998) A 
transmembrane form of the prion protein in neurodegenerative disease. 
Science (New York, N.Y, 279, 827-834. 
12. Watts, J., Drisaldi, B., Ng, V., Yang, J., Strome, B., Horne, P., Sy, M., Yoong, 
L., Young, R., Mastrangelo, P. et al. (2007) The CNS glycoprotein Shadoo 
has PrP(C)-like protective properties and displays reduced levels in prion 
infections. EMBO J. , e-pub. . 
 13 
13. Rivera-Milla, E., Stuermer, C. and Malaga-Trillo, E. (2003) An evolutionary 
basis for scrapie disease: identification of a fish prion mRNA. Trends Genet. , 
19, 72-75. 
14. Harrison, P.M., Khachane, A. and Kumar, M. (2010) Genomic assessment of 
the evolution of the prion protein gene family in vertebrates. Genomics, 95, 
268-277. 
15. Schmitt-Ulms, G., Ehsani, S., Watts, J.C., Westaway, D. and Wille, H. (2009) 
Evolutionary descent of prion genes from the ZIP family of metal ion 
transporters. PloS one, 4, e7208. 
16. Lacroute, F. (1971) Non-Mendelian mutation allowing ureidosuccinic acid 
uptake in yeast. J. Bacteriol. , 106, 519-522. 
17. Cox, B. (1965) [PSI], a cytoplasmic suppressor of super-suppression in yeast. 
Heredity, 20, 505-521. 
18. Wickner, R. (1994) [URE3] as an altered URE2 protein: evidence for a prion 
analog in Saccharomyces cerevisiae. Science (New York, N.Y, 264, 528-530. 
19. Sondheimer, N. and Lindquist, S. (2000) Rnq1: An epigenetic modifier of 
protein function in yeast. Mol. Cell, 5, 163-172. 
20. Shorter, J. and Lindquist, S. (2005) Prions as adaptive conduits of memory 
and inheritance. Nat Rev Genets, 6, 435-450. 
21. Harrison, P. and Gerstein, M. (2002) Studying genomes through the aeons: 
protein families, pseudogenes and proteome evolution. J. Mol. Biol. , 318, 
1155-1174. 
22. True, H., Berlin, I. and Lindquist, S. (2004) Epigenetic regulation of 
translation reveals hidden genetic variation to produce comlex traits. Nature, 
431, 184-187. 
23. True, H. and Lindquist, S. (2000) A yeast prion provides a mechanism for 
genetic variation and phenotypic diversity. Nature, 407, 477-483. 
24. Ross, E., Baxa, U. and Wickner, R. (2004) Scrambled prion domains form 
prions and amyloid. Mol. Cell. Biol., 24, 7206-7213. 
25. Nakayashiki, T., Kurtzman, C.P., Edskes, H.K. and Wickner, R.B. (2005) 
Yeast prions [URE3] and [PSI+] are diseases. Proc Natl Acad Sci U S A, 102, 
10575-10580. 
26. McGlinchey, R.P., Kryndushkin, D. and Wickner, R.B. (2011) Suicidal 
[PSI+] is a lethal yeast prion. Proc Natl Acad Sci U S A, 108, 5337-5341. 
27. Harrison, P. and Gerstein, M. (2003) A method to assess compositional bias 
in biological sequences and its application to prion-like glutamine/asparagine 
-rich domains in eukaryotic proteomes. Genome Biol., 4, R40 [E-pub]. 
28. Santoso, A., Chien, P., Osherovich, L. and Weissman, J. (2000) Molecular 
basis of a yeast prion species barrier. Cell, 100, 277-288. 
29. DePace, A., Santoso, A., Hillner, P. and Weissman, J. (1998) A critical role 
for amino-terminal glutamine/asparagine repeats in the formation and 
propagation of a yeast prion. Cell, 93, 1241-1252. 
30. Maddelein, M. and Wickner, R. (1999) Two Prion-Inducing Regions of 
Ure2p Are Nonoverlapping. NMol. Cell. Biol., 19, 4516-4524. 
 14 
31. Harrison, L.B., Yu, Z., Stajich, J.E., Dietrich, F.S. and Harrison, P.M. (2007) 
Evolution of budding yeast prion-determinant sequences across diverse 
fungi. J Mol Biol, 368, 273-282. 
32. Michelitsch, M.D. and Weissman, J.S. (2000) A census of 
glutamine/asparagine-rich regions: implications for their conserved function 
and the prediction of novel prions. Proc Natl Acad Sci U S A, 97, 11910-
11915. 
33. Alberti, S., Halfmann, R., King, O., Kapila, A. and Lindquist, S. (2009) A 
systematic survey identifies prions and illuminates sequence features of 
prionogenic proteins. Cell, 137, 146-158. 
34. Rogoza, T., Goginashvili, A., Rodionova, S., Ivanov, M., Viktorovskaya, O., 
Rubel, A., Volkov, K. and Mironova, L. Non-Mendelian determinant [ISP+] 
in yeast is a nuclear-residing prion form of the global transcriptional 
regulator Sfp1. Proc Natl Acad Sci U S A, 107, 10573-10577. 
35. Nemecek, J., Nakayashiki, T. and Wickner, R.B. (2009) A prion of yeast 
metacaspase homolog (Mca1p) detected by a genetic screen. Proc Natl Acad 
Sci U S A, 106, 1892-1896. 
36. Du, Z., Park, K.W., Yu, H., Fan, Q. and Li, L. (2008) Newly identified prion 
linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae. 
Nature genetics, 40, 460-465. 
37. Brown, J.C. and Lindquist, S. (2009) A heritable switch in carbon source 
utilization driven by an unusual yeast prion. Genes Dev, 23, 2320-2332. 
38. Patel, B.K., Gavin-Smyth, J. and Liebman, S.W. (2009) The yeast global 
transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat Cell 
Biol, 11, 344-349. 
39. Roberts, B.T. and Wickner, R.B. (2003) Heritable activity: a prion that 
propagates by covalent autoactivation. Genes Dev, 17, 2083-2087. 
40. Aguzzi, A. and Rajendran, L. (2009) The transcellular spread of cytosolic 
amyloids, prions, and prionoids. Neuron, 64, 783-790. 
41. Sickmeier, M., Hamilton, J.A., LeGall, T., Vacic, V., Cortese, M.S., Tantos, 
A., Szabo, B., Tompa, P., Chen, J., Uversky, V.N. et al. (2007) DisProt: the 
Database of Disordered Proteins. Nucleic Acids Res, 35, D786-793. 
42. Wickner, R.B., Edskes, H.K., Ross, E.D., Pierce, M.M., Baxa, U., 
Brachmann, A. and Shewmaker, F. (2004) Prion genetics: new rules for a 
new kind of gene. Annual review of genetics, 38, 681-707. 
43. Wickner, R.B., Edskes, H.K., Ross, E.D., Pierce, M.M., Shewmaker, F., Baxa, 
U. and Brachmann, A. (2004) Prions of yeast are genes made of protein: 
amyloids and enzymes. Cold Spring Harb Symp Quant Biol, 69, 489-496. 
44. Harrison, P.M. (2006) Exhaustive assignment of compositional bias reveals 
universally prevalent biased regions: analysis of functional associations in 
human and Drosophila. BMC Bioinformatics, 7, 441. 
45. Rogers, A., Antoshechkin, I., Bieri, T., Blasiar, D., Bastiani, C., Canaran, P., 
Chan, J., Chen, W.J., Davis, P., Fernandes, J. et al. (2008) WormBase 2007. 
Nucleic Acids Res, 36, D612-617. 
46. Harrison, P., Zheng, D., Zhang, Z., Carriero, N. and Gerstein, M. (2005) 
Transcribed processed pseudogenes in the human genome: an intermediate 
 15 
form of expressed retrosequence lacking protein-coding ability. Nucleic Acids 
Res., 33, 2374-2383. 
47. Hermjakob, H., Montecchi-Palazzi, L., Lewington, C., Mudali, S., Kerrien, 
S., Orchard, S., Vingron, M., Roechert, B., Roepstorff, P., Valencia, A. et al. 
(2004) IntAct: an open source molecular interaction database. Nucleic Acids 
Res, 32, D452-455. 
48. Harbi, D., Kumar, M. and Harrison, P.M. (2011) LPS-annotate: complete 
annotation of compositionally biased regions in the protein knowledgebase. 
Database (Oxford), 2011, baq031. 
49. Ward, J.J., McGuffin, L.J., Bryson, K., Buxton, B.F. and Jones, D.T. (2004) 
The DISOPRED server for the prediction of protein disorder. Bioinformatics, 
20, 2138-2139. 
50. Hubbard, T.J., Aken, B.L., Ayling, S., Ballester, B., Beal, K., Bragin, E., 
Brent, S., Chen, Y., Clapham, P., Clarke, L. et al. (2009) Ensembl 2009. 
Nucleic Acids Res, 37, D690-697. 
51. Berman, H., Henrick, K., Nakamura, H. and Markley, J.L. (2007) The 
worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive 
of PDB data. Nucleic Acids Res, 35, D301-303. 
52. Sali, A. and Blundell, T.L. (1993) Comparative protein modelling by 
satisfaction of spatial restraints. J Mol Biol, 234, 779-815. 
53. Larkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., McGettigan, P.A., 
McWilliam, H., Valentin, F., Wallace, I.M., Wilm, A., Lopez, R. et al. (2007) 
Clustal W and Clustal X version 2.0. Bioinformatics, 23, 2947-2948. 
54. Gould, C.M., Diella, F., Via, A., Puntervoll, P., Gemund, C., Chabanis-
Davidson, S., Michael, S., Sayadi, A., Bryne, J.C., Chica, C. et al. ELM: the 
status of the 2010 eukaryotic linear motif resource. Nucleic Acids Res, 38, 
D167-180. 
55. Tarassov, K., Messier, V., Landry, C.R., Radinovic, S., Serna Molina, M.M., 
Shames, I., Malitskaya, Y., Vogel, J., Bussey, H. and Michnick, S.W. (2008) 
An in vivo map of the yeast protein interactome. Science (New York, N.Y, 320, 
1465-1470. 
56. Derkatch, I., Bradley, M., Zhou, P., Chernoff, Y. and Liebman, S. (2001) 
Prions affect the appearance of other prions: The story of [PIN+]. Cell, 106, 
171-182. 
57. Paramithiotis, E., Pinard, M., Lawton, T., LaBoissiere, S., Leathers, V.L., 
Zou, W.Q., Estey, L.A., Lamontagne, J., Lehto, M.T., Kondejewski, L.H. et 
al. (2003) A prion protein epitope selective for the pathologically misfolded 
conformation. Nature medicine, 9, 893-899. 
58. Nelson, R., Sawaya, M., Balbirnie, M., Madsen, A., Riekel, C., Grothe, R. and 
Eisenberg, D. (2005) Structure of the cross-beta spine of amyloid-like fibrils. 
Nature, 435, 773-778. 
59. Gazit, E. (2002) A possible role for pi-stacking in the self-assembly of 
amyloid fibrils. FASEB J., 16, 77-83. 
60. Gehlenborg, N., Hwang, D., Lee, I.Y., Yoo, H., Baxter, D., Petritis, B., 
Pitstick, R., Marzolf, B., Dearmond, S.J., Carlson, G.A. et al. (2009) The 
 16 
Prion Disease Database: a comprehensive transcriptome resource for systems 
biology research in prion diseases. Database (Oxford), 2009, bap011. 
61. Pawlicki, S., Le Bechec, A. and Delamarche, C. (2008) AMYPdb: a database 
dedicated to amyloid precursor proteins. BMC Bioinformatics, 9, 273. 
 
 
 17 
 
Figure Legends  
 
Figure 1: A screenshot of an entry in the PrionOme database, for the Shadoo 
transcribed pseudogene in the human genome.  
 
Figure 2: An example of the results of a keyword search, for the term 'Anolis' in 
the 'Organism' field. Five entries for Anolis caroliensis (a lizard), appear listed.  
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Tables  
 
 
Table 1: Summary of database content   
 
PrionOme 
Classification  
Number of  
Database 
Entries 
Interactor 460  
Ortholog  949 
Paralog 205 
Prion-like 417 
Prionogenic 56 
Prionoid 6 
Pseudogene 13 
TOTAL* 2019   
 
* This is not an arithmetic sum of the individual PrionOme Classification categories, 
since some database entries have multiple PrionOme Classifications.  
 
 
Table 2: Counts of mammalian sequences in the PrionOme database with 
the sequence motif tyrosine-tyrosine-arginine (YYR)   
 
PrionOme 
Classification 
# of sequences with the 
YYR sequence motif 
# of sequences without 
the YYR sequence motif 
Prionogenic PrP 
sequences (Major Prion 
Protein) 
20 0 
Orthologs of Major Prion 
Protein 
413† 9 
Paralogs of Major Prion 
Protein 
0 120 
 
† As an example, the SQL query to obtain this data is: SELECT prion_id , name FROM main 
WHERE sequence REGEXP 'YYR' AND prion_type='Ortholog' AND taxonomy LIKE 
'%mammal%' .  
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Table 3: A summary of prionogenic and prion-like sequences in the 
PrionOme database from Saccharomyces cerevisiae, that have Q/N 
(glutamine/asparagine) and F/Y (phenylalanine/tyrosine) compositional 
biases   
 
PrionOme 
Classification 
# of sequences that 
have Q/N bias, but no  
F/Y bias 
# of sequences that 
have Q/N bias, and  
F/Y bias* 
Prionogenic**  23 5 *** 
Prion-Like**** 285 21 
 
* F/Y compositional biases with binomial P-values <=10–7 are considered (see Methods for 
details).  
** This data includes the Alberti, et al. (2009) data from screens for candidate prionogenic 
sequences.  
*** As an example, the SQL query to obtain this data is: SELECT prion_id , name FROM main 
WHERE prion_type LIKE'%Prionogenic%' AND bias REGEXP 'NY|QY|NF|QF|YN|FN|YQ|FQ' 
AND organism LIKE '%cerevisiae%' 
**** Some polymorphic sequences have been removed from these totals. 
 
 
 


